**Question:** A 2-day-old infant born at 32 weeks' gestation has had breathing difficulties since birth and is currently on a respirator and 100% oxygen. These difficulties occur because of which one of the following?

A. Respiratory distress syndrome (RDS)
B. Patent ductus arteriosus (PDA)
C. Congenital heart defects
D. Hypotension

**Correct Answer:** A. Respiratory distress syndrome (RDS)

**Core Concept:**
Respiratory distress syndrome (RDS) is a pulmonary condition affecting premature infants due to immature lung development, surfactant deficiency, and alveolar overdistension. Surfactant is a substance that helps reduce surface tension in the lungs, preventing alveoli from collapsing. In premature infants, surfactant production is inadequate, leading to impaired gas exchange and respiratory distress.

**Why the Correct Answer is Right:** RDS is the most likely cause of the described infant's breathing difficulties because:

1. **Infants born prematurely:** The infant in the question is born at 32 weeks' gestation, which is considered premature. Premature infants are at higher risk for developing RDS due to their immature lungs and reduced surfactant production.
2. **Inadequate surfactant production:** Premature infants have insufficient surfactant production, leading to increased surface tension in the alveoli and impaired gas exchange. This results in respiratory distress and the need for mechanical ventilation and high oxygen concentrations to support the infant's breathing.

**Why Each Wrong Option is Incorrect:**

A. Patent ductus arteriosus (PDA) is a congenital heart defect that affects infants; it is not a respiratory condition and does not explain the described breathing difficulties.
B. Congenital heart defects can lead to cyanosis, not respiratory distress. These conditions require different treatment strategies compared to RDS.
D. Hypotension is a circulatory issue, not a respiratory problem. Hypotension would not explain the described respiratory distress in a premature infant.

**Clinical Pearl:** To improve the chances of preventing RDS in premature infants, healthcare providers should focus on:

1. **Prophylactic surfactant therapy:** Administering surfactant prophylaxis can reduce the incidence of RDS in premature infants by promoting surfactant production and protecting alveolar cells from hypoxia-induced injury.
2. **Oxygen supplementation:** Providing adequate oxygen levels (e.g., 100% oxygen therapy) is essential for premature infants to facilitate gas exchange but should be used judiciously to prevent oxygen toxicity and lung injury.
3. **Management of ventilation settings:** Appropriate ventilation settings, such as low tidal volumes and low positive end-expiratory pressure, can help prevent alveolar rupture and subsequent lung injury.

In summary, RDS is the most likely explanation for the described respiratory distress in this premature infant due to its connection with immature lungs, surfactant deficiency, and the need for mechanical ventilation and high oxygen concentrations. Appropriate management strategies, including prophylactic surfactant therapy,